YMABSConnect – Just another WordPress site
Intended for US audiences only.
DANYELZA® (naxitamab-gqgk)
40 mg/10 mL INJECTION

Monday through Friday 8AM to 8PM ET at 1-833-33YMABS (1-833-339-6227), option (2)

Please click for full Prescribing Information and Patient Information for DANYELZA including Boxed Warning on serious infusion-related reactions and nervous system problems, and talk to your doctor.

Provides answers to questions related to access, insurance, financial support programs and other resource programs for qualifying patients.

Jump to health care professional section
Speak to a case manager

Monday through Friday 8AM to 8PM ET at 1-833-33YMABS (1-833-339-6227), option (2)

Patients and caregivers

Do you have questions about your insurance or affording a prescribed Y-mAbs product?

Y-mAbs Connect has a dedicated team of case managers who can:

  • Research your insurance coverage questions for DANYELZA
  • Answer your questions about Y-mAbs Connect financial support programs for qualifying patients
  • Provide you with information about other financial or logistical support programs that may be available to you

If you are uninsured or need help affording DANYELZA® (naxitamab-gqgk), speak to a Y-mAbs Connect case manager to see if you qualify for 1 of the financial support programs below:

Y-mAbs Connect Co-pay Program

If you are eligible,* this program could help reduce your out-of-pocket costs for DANYELZA.

Y-mAbs Connect Patient Assistance Program (PAP)

If you are eligible,* this program may be able to
provide DANYELZA at no cost.

Y-mAbs Therapeutics, Inc. reserves the right at any time, and without notice, to modify or discontinue these programs and any support provided to the patient.

*You must meet certain eligibility criteria for these programs. Speak to a case manager to ask about your eligibility.

Independent third-party organizations

Y-mAbs Connect case managers can provide information about other organizations that may provide financial, travel, and other logistical support. Eligibility criteria may vary by organization.

Third-party organizations are independent of Y-mAbs Therapeutics, Inc.

Speak with your doctor about enrolling in Y-mAbs Connect

Health care professionals

If you have questions about your patient’s insurance coverage, eligibility for financial support programs, or enrollment in Y-mAbs Connect, our case managers can help.

Y-mAbs Connect case managers can address questions about:

  • Your patient’s insurance coverage such as a benefits investigation for DANYELZA® (naxitamab-gqgk) 40 mg/10 mL Injection
  • Your patient’s eligibility for available financial support programs provided by Y-mAbs Connect and independent third-party programs
  • Logistics around the delivery of medication

Enroll your patient in Y-mAbs Connect

Enroll your patient in Y-mAbs Connect prior to ordering DANYELZA.

Download the How to Order DANYELZA form to the right

Please click for full Prescribing Information and Patient Information for DANYELZA including Boxed Warning on serious infusion-related reactions and neurotoxicity.